The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when ...
Please provide your email address to receive an email when new articles are posted on . Maternal folate levels that were too low or too high were associated with risk of congenital heart disease in ...
FDA approves leucovorin as the first treatment for FOLR1-related cerebral folate deficiency, while evidence remains insufficient for autism treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results